inflammatori
airway
diseas
major
caus
morbid
mortal
common
chronic
respiratori
diseas
asthma
chronic
obstruct
pulmonari
diseas
copd
affect
around
million
million
peopl
worldwid
respect
diseas
character
chronic
inflamm
respiratori
tract
worsen
acut
exacerb
lead
airway
obstruct
wheez
breathless
main
caus
exacerb
infect
respiratori
virus
includ
rhinoviru
respiratori
syncyti
viru
rsv
influenza
studi
determin
aetiolog
exacerb
detect
respiratori
virus
asthma
exacerb
copd
exacerb
airway
epithelium
main
target
respiratori
virus
pattern
recognit
receptor
prr
surfac
within
epitheli
cell
recogn
compon
virus
activ
rang
signal
pathway
includ
mitogenactiv
protein
kinas
mapk
pathway
mapk
pathway
consist
threetier
kinas
cascad
culmin
dualphosphoryl
activ
mapk
extracellular
signalregul
kinas
erk
jun
ntermin
kinas
jnk
protein
transloc
nucleu
activ
rang
transcript
factor
lead
product
releas
mani
differ
molecul
includ
interferon
cytokin
adhes
molecul
initi
inflammatori
respons
respons
aberr
patient
underli
airway
diseas
reason
remain
incomplet
understood
involv
impair
control
viral
infect
damag
epithelium
alter
lymphocyt
respons
review
discuss
role
mapk
pathway
process
regul
group
protein
known
dualspecif
phosphatas
dusp
mapk
phosphatas
mkp
specif
role
mapk
pathway
examin
use
small
molecul
inhibitor
pyridinyl
imidazol
compound
inhibit
compet
atp
bind
site
block
catalyt
activ
griego
et
al
use
two
pyridinyl
imidazol
inhibitor
examin
role
cytokin
chemokin
product
human
bronchial
epitheli
cell
line
respons
infect
rhinoviru
found
infect
caus
time
dosedepend
increas
phosphoryl
treatment
either
inhibitor
prior
infect
led
signific
reduct
secret
cytokin
chemokin
examin
includ
growthrel
granulocyt
colonystimul
factor
gcsf
granulocytemacrophag
colonystimul
factor
gmcsf
import
role
neutrophilia
recent
work
further
knowledg
show
reduc
product
primari
bronchial
epitheli
cell
signal
inhibit
prior
infect
rhinoviru
inhibitor
also
use
highlight
import
inflammatori
cytokin
product
respons
respiratori
virus
treatment
cell
decreas
releas
respons
rsv
infect
respons
parainfluenza
viru
infect
support
inhibit
primari
bronchial
epitheli
cell
reduc
mrna
product
respons
rsv
infect
proinflammatori
role
also
demonstr
vivo
treatment
influenzainfect
balbc
mice
lower
concentr
protein
lung
homogen
erk
pathway
also
role
cytokin
induct
epitheli
cell
respons
viral
infect
liu
et
al
newcomb
et
al
treat
airway
epitheli
cell
line
prior
rhinovir
infect
inhibit
erk
pathway
block
activ
upstream
kinas
treatment
drug
reduc
secret
respons
rhinoviru
almost
baselin
level
howev
replic
primari
bronchial
epitheli
cell
treat
mek
inhibitor
could
due
differ
potenc
two
chemic
inhibitor
primari
immort
cell
erk
signal
also
induc
inflammatori
cytokin
releas
respons
infect
rsv
decreas
level
supernat
infect
cell
treat
less
known
role
jnk
pathway
inflammatori
cytokin
product
viral
infect
airway
one
studi
show
weaker
product
releas
respons
infect
two
strain
rhinoviru
primari
bronchial
epitheli
cell
treat
jnk
inhibitor
togeth
studi
illustr
central
role
mapk
inflammatori
respons
respiratori
viral
infect
precis
contribut
pathway
seem
depend
specif
viru
cell
type
studi
togeth
induc
larg
proport
inflammatori
cytokin
product
respiratori
epitheli
cell
releas
type
type
iii
interferon
respons
viral
infect
figur
interferon
limit
replic
respiratori
virus
pretreat
airway
epitheli
cell
significantli
reduc
replic
rhinoviru
influenza
viru
sever
virus
includ
influenza
rsv
target
compon
interferon
pathway
order
limit
antivir
respons
highli
pathogen
strain
influenza
induc
lower
level
interferon
mapk
pathway
previous
implic
interferon
induct
respons
influenza
infect
infect
mdck
cell
chicken
macrophag
avian
influenza
virus
presenc
jnk
inhibitor
led
increas
viral
replic
due
decreas
activ
recent
gene
express
array
compar
respons
primari
huvec
infect
highli
pathogen
avian
influenza
virus
without
inhibitor
addit
diminish
product
inflammatori
mediat
inhibit
reduc
express
signal
erk
also
link
interferon
signal
rsv
infect
erk
inhibit
cell
lessen
activ
respons
rsv
identifi
mapk
key
pathway
antivir
proinflammatori
respons
viral
infect
figur
addit
regul
respiratori
viral
infect
interferon
respons
mapk
may
also
role
viral
life
cycl
marchant
et
al
show
inhibit
use
bronchial
epitheli
cell
line
reduc
replic
number
respiratori
virus
includ
influenza
rsv
coxsacki
viru
human
parainfluenza
viru
adenoviru
influenza
genom
replic
occur
within
nucleu
form
viral
ribonucleoprotein
vrnp
complex
export
cytoplasm
inhibit
either
erk
found
decreas
influenza
viru
replic
mdck
cell
due
reduct
vrnp
export
nucleu
nencioni
et
al
hypothes
due
phosphoryl
vrnp
affect
affin
viral
surfac
protein
support
coloc
vrnp
nucleu
mdck
cell
reduct
vrnp
phosphoryl
inhibit
role
mapk
pathway
rsv
replic
also
investig
inhibit
erk
diminish
level
viral
rna
progeni
releas
cell
case
thought
due
impair
transport
viral
protein
secretori
pathway
inhibit
vero
cell
decreas
phosphoryl
sh
protein
viral
membran
protein
unknown
function
alter
cellular
distribut
sh
increas
local
golgi
impli
phosphoryl
sh
may
necessari
transport
secretori
pathway
thu
viral
assembl
similar
role
propos
erk
treatment
cell
reduc
surfac
express
viral
f
protein
rsv
influenza
virus
also
success
evad
immun
respons
antivir
therapi
direct
cell
cell
spread
rsv
form
syncytia
airway
epithelium
fuse
membran
neighbor
cell
lead
cytosol
mix
viral
transfer
rsv
also
induc
format
long
filament
reach
spread
distant
cell
process
depend
actin
rearrang
rhoa
complex
wound
heal
assay
inhibit
erk
epitheli
cell
line
reduc
recruit
actin
polymer
indic
possibl
role
erk
syncytia
format
rsv
infect
erk
previous
implic
syncytia
format
cancer
treatment
choriocarcinoma
cell
line
mitig
syncytia
format
one
result
syncytia
format
rsv
infect
disrupt
epithelium
decreas
membran
barrier
integr
lead
pneumonia
secondari
bacteri
infect
model
cell
rsv
infect
lower
transepitheli
resist
caus
paracellular
gap
format
treatment
cell
lessen
effect
rsv
infect
cell
monolay
associ
reduc
phosphoryl
heat
shock
protein
protein
involv
actin
rearrang
suggest
may
also
involv
syncytia
format
mapk
involv
wide
varieti
process
may
also
indirectli
involv
viral
replic
exampl
enterovirus
rhinoviru
util
host
cell
endocytosi
machineri
mainli
protein
traffic
cholesterol
replic
organel
shown
phosphoryl
activ
guanylnucelotid
dissoci
inhibitor
protein
facilit
cycl
rab
protein
membran
cytosol
endocytosi
cholesterol
play
import
role
viral
polyprotein
process
genom
synthesi
inhibit
cholesterol
traffick
block
viral
replic
thu
activ
rab
protein
cycl
may
facilit
viral
replic
overal
literatur
suggest
respiratori
virus
hijack
mapk
downstream
target
end
util
protein
traffick
viral
assembl
cell
cell
spread
highlight
need
strict
regul
pathway
order
limit
viral
replic
propos
mapk
target
antivir
therapi
defin
featur
asthma
copd
goblet
cell
hyperplasia
excess
mucu
product
lead
blockag
airway
contribut
asthmaassoci
death
predomin
mucin
asthma
copd
helper
cytokin
thought
main
induc
goblet
cell
hyperplasia
product
murin
model
asthma
activ
mapk
also
particip
process
inhibit
erk
differenti
primari
murin
human
airway
epitheli
cell
monolay
reduc
induc
upregul
goblet
cell
number
express
furthermor
activ
respons
weaker
epitheli
cell
knock
mice
indic
mucin
product
occur
via
respiratori
viral
infect
also
shown
upregul
mucu
product
doublestrand
rna
common
compon
replic
intermedi
virus
stimul
cell
doublestrand
rna
upregul
express
mucin
could
revers
treatment
inhibitor
express
rais
ovalbumin
murin
model
asthma
increas
rsv
infect
observ
may
depend
level
higher
lung
rsvinfect
mice
lead
enhanc
product
addit
treatment
raw
cell
mapk
inhibitor
decreas
releas
respons
rsv
inhibit
also
shown
repress
product
primari
nasal
epitheli
cell
respons
stimul
anoth
mechan
mucin
product
upregul
via
activ
egf
receptor
egfr
rasrafmekerk
pathway
rhinoviru
infect
differenti
primari
human
tracheal
epitheli
cell
upregul
rna
level
protein
releas
well
rna
induct
mediat
egfr
pathway
treatment
mek
egfr
inhibitor
return
level
baselin
author
hypothes
due
autocrin
loop
rhinovir
infect
induc
product
releas
egrf
ligand
shown
cell
activ
egrf
cell
surfac
thu
activ
erk
pathway
highlight
role
mapk
viral
induc
mucu
product
substanti
implic
airway
diseas
mucu
hyperplasia
common
symptom
much
literatur
regard
dusp
innat
immun
focus
bacteri
infect
studi
examin
role
viral
infect
archetyp
famili
well
studi
nuclear
protein
capabl
dephosphoryl
jnk
erk
substrat
specif
depend
stimuli
cell
type
character
earli
respons
gene
undetect
express
baselin
rapid
upregul
upon
exposur
varieti
stimuli
airway
epitheli
cell
line
upregul
mrna
within
one
hour
respons
synthet
doublestrand
rna
molecul
polyinosin
polycytidyl
acid
poli
c
poli
c
ligand
prr
tolllik
receptor
rigilik
receptor
rlr
predominantli
activ
viral
infect
knock
express
use
smallinterf
rna
sirna
cell
amplifi
releas
two
proinflammatori
cytokin
respons
poli
c
stimul
similar
role
seen
infect
cell
line
avian
coronaviru
infecti
bronchiti
viru
sirna
treatment
increas
mrna
level
respons
infect
augment
cytokin
express
like
due
elev
mapk
activ
increas
level
phosphoryl
jnk
found
rsv
infect
cell
treat
sirna
also
implic
regul
interferon
respons
knock
hepatocyt
cell
line
increas
activ
respons
hepat
c
viru
stimul
howev
yeast
twohybrid
assay
unabl
find
interact
overexpress
cell
affect
level
activ
respons
thu
effect
knock
interferon
respons
hepat
c
infect
may
indirect
effect
increas
mapk
activ
section
rather
direct
inactiv
inflammatori
cytokin
induc
respiratori
viral
infect
higher
express
asthmat
patient
elicit
secondari
inflammatori
cytokin
releas
airway
smooth
muscl
asm
cell
stimul
primari
asm
cell
also
caus
upregul
mrna
protein
express
knock
asm
cell
releas
increas
respons
stimul
neutrophil
chemoattract
commonli
detect
asthmat
airway
neutrophilia
harm
airway
caus
epitheli
cell
damag
necrosi
level
correl
asthma
sever
stimul
epitheli
cell
also
induc
express
mucin
knock
cell
amplifi
express
airway
mucin
respons
taken
togeth
work
suggest
import
role
respons
epithelium
insult
includ
regul
inflammatori
cytokin
mucin
product
express
ubiquit
nucleu
cytoplasm
upregul
respons
viral
infect
bonemarrow
deriv
macrophag
bmdm
infect
influenza
viru
stimul
poli
c
enhanc
mrna
protein
express
knock
primari
bronchial
epitheli
cell
increas
releas
neutrophil
chemoattract
respons
stimul
key
proinflammatori
cytokin
suggest
like
neg
regul
inflammatori
respons
airway
importantli
rhinovir
infect
airway
epitheli
cell
monocyt
caus
releas
combin
stimul
rhinoviru
lead
even
greater
inflammatori
respons
knock
primari
bronchial
epitheli
cell
healthi
copd
donor
identifi
central
regul
inflammatori
respons
respiratori
virus
infect
epitheli
cell
induc
releas
act
back
epithelium
promot
inflamm
neg
regul
role
respiratori
viral
infect
also
examin
vivo
knock
mice
infect
influenza
elev
level
bronchoalveolar
lavag
bal
wildtyp
mice
interestingli
knock
mice
also
decreas
viral
titr
better
surviv
respons
infect
associ
rais
express
phosphoryl
therefor
increas
interferon
ifn
express
investig
establish
directli
interact
indic
novel
substrat
highlight
import
regul
inflammatori
respons
also
antivir
respons
sustain
uncontrol
pulmonari
inflamm
lead
acut
lung
injuri
often
seen
sever
influenza
infect
murin
model
acut
lung
injuri
gener
intratrach
inject
lipopolysaccharid
lp
agonist
knock
mice
util
acut
lung
injuri
model
exhibit
greater
diseas
sever
wildtyp
mice
increas
lung
injuri
pulmonari
edema
associ
augment
neutrophil
influx
lung
inflammatori
cytokin
bal
bmdm
isol
mice
elev
activ
jnk
lesser
extent
erk
respons
lp
treatment
adopt
transfer
bmdm
wildtyp
mice
led
enhanc
lung
inflamm
respons
intratrach
lp
inject
transfer
wildtyp
bmdm
keep
vitro
data
describ
demonstr
antiinflammatori
role
airway
import
limit
immunemedi
lung
damag
interestingli
one
dusp
found
proinflammatori
role
murin
model
acut
lung
injuri
respons
intratrach
lp
inject
knock
mice
decreas
inflammatori
cytokin
bal
neutrophil
infiltr
lung
data
fit
earlier
studi
show
proinflammatori
role
sepsi
improv
surviv
knock
mice
bmdm
taken
mice
produc
lower
level
inflammatori
cytokin
respons
lp
inject
wildtyp
mice
associ
reduc
activ
jnk
increas
activ
erk
author
suggest
due
erkinduc
transcript
demonstr
previous
studi
indic
differ
dusp
may
pro
antiinflammatori
role
pulmonari
inflamm
note
almutairi
et
al
found
conflict
result
knock
bmdm
releas
higher
level
inflammatori
cytokin
respons
lp
although
unclear
studi
differ
sever
studi
implic
dusp
regul
cell
differenti
helper
subset
tabl
knock
mice
util
demonstr
role
cell
prime
prolifer
cell
subset
skew
antigen
present
cell
apc
dendrit
cell
role
alter
respons
knock
dendrit
cell
increas
activ
thu
alter
cytokin
product
led
impair
prime
wildtyp
cell
reduc
differenti
cell
augment
treg
cell
differenti
knock
cell
exhibit
reduc
prolifer
respons
activ
antibodi
lower
level
cytokin
respect
cytokin
level
remain
unchang
studi
emphas
differ
role
differ
cell
type
knock
differ
effect
apc
mediat
cell
intrins
respons
overal
effect
knock
observ
influenza
infect
declin
cell
number
lead
impair
control
viru
greater
diseas
sever
alter
respons
associ
decreas
nuclear
transloc
transcript
factor
import
cell
prolifer
function
jnk
previous
found
neg
regul
phosphoryl
impli
impair
cell
respons
knock
mice
due
increas
jnk
activ
also
play
role
cell
prolifer
knock
mice
decreas
number
viru
specif
cell
cell
lung
respons
influenza
infect
mice
also
diminish
cell
prolifer
respons
antibodi
howev
cell
effector
function
increas
greater
level
cytokin
releas
elev
cytokin
releas
also
observ
respons
secondari
infect
lymphocyt
choriomening
viru
lead
immunemedi
death
three
dusp
also
implic
helper
subset
skew
neg
regul
treg
cell
differenti
inactiv
activ
requir
induct
treg
cell
overexpress
cell
reduc
phosphoryl
respons
stimul
coimmunoprecipit
indic
directli
dephosphoryl
knock
mice
increas
number
treg
cell
fewer
cell
contrast
neg
regulatori
role
treg
cell
gener
seem
act
posit
regul
mice
overexpress
decreas
inflamm
diseas
sever
collageninduc
arthriti
model
due
rais
number
treg
cell
higher
activ
reduc
cell
lower
activ
knock
show
embryon
lethal
howev
mice
express
domin
neg
protein
gener
alter
balanc
cell
isol
mice
produc
increas
level
diminish
respons
antibodi
ovalbumin
contrast
mice
knock
specif
hematopoiet
compart
display
alter
respons
demonstr
role
protein
regul
product
mice
enhanc
releas
cell
prolifer
compar
wildtyp
mice
respons
antibodi
associ
increas
activ
erk
critic
express
previous
shown
inhibit
expans
cell
mice
exhibit
decreas
number
produc
cell
revers
treatment
erk
inhibitor
addit
role
cell
prolifer
helper
subset
skew
dusp
also
found
regul
cell
receptor
tcr
signal
bind
tcr
antigen
lead
recruit
lck
tyrosin
kinas
phosphoryl
chain
lead
recruit
initi
rang
signal
pathway
lck
knock
mice
emphas
import
induct
tcr
signal
cell
isol
jkap
knock
mice
higher
activ
level
sever
molecul
downstream
tcr
includ
lck
ikk
mapk
respons
antibodi
lck
coimmunoprecipit
murin
splenic
cell
found
dephosphoryl
lck
inactiv
downstream
activ
bind
induc
activ
conform
chang
trigger
ikk
jnk
pathway
mkpl
knock
cell
stimul
antibodi
number
activ
cell
significantli
higher
wildtyp
cell
investig
reason
behind
cell
transfect
wildtyp
nonfunct
mutant
stimul
antibodi
level
activ
lck
unchang
cell
express
wildtyp
mutat
howev
ikk
mapk
activ
increas
cell
express
mutat
mass
spectrometri
use
identifi
bind
protein
target
analysi
reveal
dephosphoryl
residu
data
illustr
dusp
fundament
role
adapt
immun
affect
activ
prolifer
differenti
helper
cell
although
mani
studi
examin
cell
isol
identifi
dusp
import
regul
suggest
essenti
role
airway
diseas
exacerb
asthma
copd
treat
corticosteroid
limit
inflammatori
respons
steroid
interact
glucocorticoid
receptor
gr
cytosol
induc
conform
chang
allow
gr
transloc
nucleu
interact
inhibit
transcript
factor
recent
evid
reveal
steroid
mediat
mani
action
treatment
glucocorticoid
dexamethason
increas
express
airway
epitheli
cell
line
airway
smooth
muscl
cell
mous
model
dexamethason
treatment
reduc
releas
inflammatori
cytokin
serum
respons
lp
inject
inhibitori
action
dexamethason
weaken
knock
mice
bmdm
periton
macrophag
isol
knock
mice
show
due
impair
inhibit
mapk
activ
thu
cytokin
releas
respons
lp
present
dexamethason
treatment
also
promot
wound
heal
respons
upregul
protein
arginas
fibroblast
growth
factor
diminish
periton
macrophag
isol
knock
mice
respons
altern
macrophag
activ
indic
restrict
inflamm
promot
wound
heal
interestingli
bonemarrow
deriv
mast
cell
knock
mice
differ
wildtyp
level
cytokin
releas
respons
ige
crosslink
dexamethason
treatment
may
due
redund
within
dusp
famili
dexamethason
also
upregul
dusp
suggest
action
dusp
dexamethason
treatment
differ
depend
cell
type
stimulu
role
steroid
treatment
airway
epithelium
also
investig
sirna
knock
cell
line
block
antiinflammatori
action
dexamethason
mapk
activ
cytokin
releas
respons
around
asthmat
resist
steroid
treatment
sever
studi
examin
differ
respons
asthmat
sensit
steroid
resist
bronchial
biopsi
steroidsensit
asthmat
show
reduct
jnk
activ
treatment
dexamethason
seen
bronchial
biopsi
steroidresist
asthmat
higher
activ
level
also
detect
alveolar
macrophag
isol
steroidresist
asthmat
steroidsensit
cell
associ
reduc
express
respons
dexamethason
lower
express
also
found
peripher
blood
neutrophil
steroidresist
asthmat
comparison
steroidsensit
asthmat
exacerb
asthma
copd
caus
viral
bacteri
infect
also
resist
steroid
treatment
nonvir
exacerb
rhinoviru
infect
impair
antiinflammatori
action
steroid
partli
reduc
nuclear
transloc
glucocorticoid
receptor
treatment
cell
dexamethason
reduc
inflammatori
cytokin
releas
upregul
respons
stimul
howev
cell
infect
rhinoviru
suppress
dexamethason
abrog
upregul
express
treatment
cell
ligand
also
induc
steroid
resist
effect
express
howev
treatment
induc
oxid
stress
proport
present
cell
oxid
oxid
catalyt
cystein
residu
activ
site
dusp
render
inact
find
suggest
steroid
insensit
asthmat
infect
airway
may
due
defect
express
activ
furthermor
polymorph
gene
associ
steroid
respons
role
dusp
steroid
treatment
remain
investig
anoth
therapi
commonli
use
treat
asthmat
bronchodil
agonist
addit
bronchodil
also
antiinflammatori
effect
treatment
cell
increas
intracellular
level
camp
promot
contain
camprespons
element
treatment
airway
epitheli
cell
line
airway
smooth
muscl
cell
found
upregul
express
role
antiinflammatori
action
salbutamol
investig
induc
paw
edema
wildtyp
knock
mice
salbutamol
treatment
reduc
level
inflamm
around
wildtyp
mice
around
knock
mice
signifi
also
import
role
mediat
antiinflammatori
effect
addit
corticosteroid
suggest
sever
dusp
may
dysregul
peopl
asthma
intrigu
explan
excess
inflammatori
respons
seen
patient
particularli
activ
mapk
protein
elev
asthmat
baselin
level
phosphoryl
higher
bronchial
epitheli
cell
isol
asthmat
healthi
control
phosphoryl
erk
greater
cell
isol
asthmat
baselin
respons
antibodi
studi
isol
nasal
epitheli
cell
healthi
individu
patient
hous
dust
mite
allergi
common
allergi
associ
asthma
perform
microarray
determin
gene
express
chang
respons
stimul
hous
dust
mite
nonallerg
control
mrna
express
upregul
respons
hous
dust
mite
challeng
howev
allerg
patient
express
alter
alter
express
activ
also
observ
sarcoidosi
sarcoidosi
system
inflammatori
disord
often
character
granuloma
within
lung
rastogi
et
al
isol
cultur
leukocyt
bal
control
sarcoidosi
patient
activ
level
inflammatori
cytokin
product
higher
cell
isol
patient
baselin
prr
stimul
coincid
much
lower
protein
express
control
sarcoidosi
patient
find
suggest
impair
upregul
reason
enhanc
inflammatori
respons
asthma
sarcoidosi
cigarett
smoke
exposur
lead
develop
asthma
common
caus
copd
partial
induct
inflammatori
respons
lung
higher
level
inflammatori
cytokin
detect
lung
smoker
higher
level
activ
also
detect
smoker
lung
treatment
cell
inhibitor
reduc
releas
cytokin
respons
cigarett
smoke
may
also
role
process
ferret
expos
cigarett
smoke
six
month
reduc
level
protein
lung
tissu
although
function
effect
yet
examin
may
also
differenti
express
asthmat
patient
transcript
profil
cell
taken
asthmat
healthi
subject
show
lower
baselin
mrna
express
asthmat
cell
healthi
cell
intriguingli
singl
nucleotid
polymorph
gene
identifi
genet
screen
variant
associ
sever
asthma
howev
statist
signific
possibl
due
limit
number
patient
studi
studi
examin
relationship
dusp
asthma
would
interest
yet
carri
mapk
pathway
import
role
airway
inflamm
aberrantli
activ
sever
inflammatori
airway
diseas
may
part
due
alter
express
dusp
lower
baselin
level
lower
induct
express
upon
allergen
stimul
steroid
treatment
asthmat
dusp
central
role
regul
inflamm
therefor
aberr
express
could
import
function
pathogenesi
lung
inflamm
underli
airway
diseas
also
lead
greater
suscept
lower
respiratori
tract
infect
due
impair
control
viral
replic
literatur
discuss
suggest
possibl
role
dusp
control
viralinduc
exacerb
airway
diseas
term
regul
mapk
role
viral
life
cycl
also
ifn
product
cell
prolifer
skew
current
treatment
airway
inflamm
alway
effect
caus
signific
side
effect
therefor
develop
new
specif
treatment
extrem
import
mapk
inhibitor
investig
therapeut
applic
vari
success
altern
method
reduc
inflamm
would
via
upregul
dusp
mechan
may
achiev
review
previous
dusp
repres
potenti
target
novel
antiinflammatori
treatment
airway
diseas
futur
work
role
airway
imper
